# GlucoTrack, Inc. (GCTK)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GCTK/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -8.15M | $ -7.66M | $ 19.0K | $ -1.74M |
| 2025 | $ 0 | $ -19.85M | $ -15.70M | $ 33.0K | $ 2.83M |
| 2024 | $ 0 | $ -23.75M | $ -13.24M | $ 267.0K | $ -13.00M |
| 2023 | $ 0 | $ -7.67M | $ -7.09M | $ 196.0K | $ 3.20M |
| 2022 | $ 0 | $ -4.95M | $ -4.17M | $ 195.0K | $ 1.23M |
| 2021 | $ 0 | $ -4.83M | $ -4.49M | $ 250.0K | $ 5.16M |
| 2020 | $ -2.9K | $ -3.43M | $ -4.53M | $ 363.0K | $ 8.98M |
| 2019 | $ 269.5K | $ -4.54M | $ -5.06M | $ 378.0K | $ -1.41M |
| 2018 | $ 57.4K | $ -8.87M | $ -6.47M | $ 168.2K | $ -2.87M |
| 2017 | $ 794.1K | $ -13.91M | $ -7.97M | $ 182.8K | $ -16.57M |
| 2016 | $ 841.6K | $ -7.44M | $ -7.41M | $ 162.0K | $ -10.95M |
| 2015 | $ 201.0K | $ -8.20M | $ -6.61M | $ 160.3K | $ -6.97M |
| 2014 | $ 84.5K | $ 4.21M | $ -4.84M | $ 618.0K | $ -4.83M |
| 2013 | $ 0 | $ -13.93M | $ -4.67M | $ 693.1K | $ -11.06M |
| 2012 | $ 0 | $ -4.00M | $ -3.33M | $ 37.4K | $ -503.1K |
| 2011 | $ 0 | $ -3.47M | $ -2.90M | $ 606.1K | $ 968.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.01 |
| Liabilities / Eq | -1.86 |
| Current Ratio | 0.46 |

## Other views

- [Metrics](https://sponda.capital/en/GCTK.md)
- [Charts](https://sponda.capital/en/GCTK/charts.md)
- [Compare](https://sponda.capital/en/GCTK/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.